+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate

Malaria Journal 12: 359

Drug repurposing or repositioning refers to the usage of existing drugs in diseases other than those it was originally used for. For diseases like malaria, where there is an urgent need for active drug candidates, the strategy offers a route to significantly shorten the traditional drug development pipelines. Preliminary high-throughput screens on patent expired drug libraries have recently been carried out for Plasmodium falciparum. This study reports the systematic and objective further interrogation of selected compounds reported in these studies, to enable their repositioning as novel stand-alone anti-malarials or as combinatorial partners. SYBR Green flow cytometry and micro-titre plate assays optimized in the laboratory were used to monitor drug susceptibility of in vitro cultures of P. falciparum K1 parasite strains. Previously described fixed-ratio methods were adopted to investigate drug interactions. Emetine dihydrochloride hydrate, an anti-protozoal drug previously used for intestinal and tissue amoebiasis was shown to have potent inhibitory properties (IC₅₀ doses of ~ 47 nM) in the multidrug resistant K1 strain of P. falciparum. The sum 50% fractional inhibitory concentration (∑FIC₅₀, ₉₀) of the interaction of emetine dihydrochloride hydrate and dihydroartemisinin against the K1 strains of P. falciparum ranged from 0.88-1.48. The results warrant further investigation of emetine dihydrochloride hydrate as a potential stand-alone anti-malarial option. The interaction between the drug and the current front line dihydroartemisinin ranged from additive to mildly antagonistic in the fixed drug ratios tested.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052720856

Download citation: RISBibTeXText

PMID: 24107123

DOI: 10.1186/1475-2875-12-359

Related references

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum. Malaria Journal 9: 326, 2010

Does anti-malarial drug knowledge predict anti-malarial dispensing practice in drug outlets? A survey of medicine retailers in western Kenya. Malaria Journal 11: 263, 2012

The State of the Art in Anti-Malarial Drug Discovery and Development. Current Topics in Medicinal Chemistry 11(10): 1226-1254, 2011

The state of the art in anti-malarial drug discovery and development. Current Topics in Medicinal Chemistry 11(10): 1226-1254, 2011

Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs. Malaria Journal 15: 50, 2016

In vitro evaluation of anti malarial drug combinations. Proceedings of the Helminthological Society of Washington 39(SPECIAL ISSUE): 292-297, 1972

Malaria burden and anti-malarial drug efficacy in Owando, northern Congo. Malaria Journal 15: 16, 2016

CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives. Malaria Journal 9: 202, 2010

In vitro studies of anti malarial drug resistance in Plasmodium falciparum. Punjab University Journal of Zoology 17: 23-27, 2002

Reduced deformability of parasitized red blood cells as a biomarker for anti-malarial drug efficacy. Malaria Journal 14: 428, 2015

Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali. Malaria Journal 18(1): 40, 2019

Prospective in vitro testing for drug-induced neutropenia in a patient requiring anti-malarial prophylaxis: confirmation of findings on exposure of patient to drug. Clinical and Laboratory Haematology 12(1): 31-36, 1990

In vitro anti-malarial drug susceptibility of temperate Plasmodium vivax from central China. American Journal of Tropical Medicine and Hygiene 85(2): 197-201, 2011

The x ray crystal structure of the anti malarial and anti leprotic drug 4 4 di aminodiphenyl sulfone. Chemical Communications (Journal of the Chemical Society Section D) 15: 920-921, 1970

Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties. Oncotarget 7(33): 52928-52939, 2016